Company Data
HilleVax Inc.
Ticker
HLVX
Current Price
$1.85 -0.54%
Market Cap
$92.8M
Price Target
Refer to Report
Volume
8.6K
52wk Range
$1.34 - $15.6
Overview
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm’s initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.